Yimei Bao

Quantitative determination of anti-tumor agent bis(4-fluorobenzyl)trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography.

Xiao Xu, Xiaobo Wang, H. An, 2008, Journal of pharmaceutical and biomedical analysis.

Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC

Xiaoying Zhang, Xiao Xu, Lijun Xu, 2020, Medicine in Drug Discovery.

Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.

H. An, Xiaopeng Mo, Xiaoying Xu, 2008, Journal of pharmaceutical and biomedical analysis.

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.

J. Teijaro, Wanhong Xu, Lisa Kerwin, 2024, i Medicina.

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.

J. Teijaro, Wanhong Xu, Lisa Kerwin, 2023, i Medicina.